Details of Disease

Disease Name

Pancreatic malfunction

Disease Class

DC30-DC3Z: Pancreatic malfunction

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISM48JC: Pancreatic malfunction

ICD-11

ICD-11: DC30-DC3Z

Expand ICD-11

'DC3Z

Expand ICD-10

'K80-K87; 'K87; 'K87.1

General Information of Disease (ID: DISM48JC)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Ultrase	DM0WOYR	Approved	NA	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Pancrecarb	DMOML9Q	NDA filed	NA	[2]
Dexloxiglumide	DM52HUD	Phase 2	Small molecular drug	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 3 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Pranazepide	DMP43IR	Discontinued in Phase 2	Small molecular drug	[3]
T-0632	DML4M5K	Discontinued in Phase 1	Small molecular drug	[4]
Lorglumide	DM904B6	Terminated	Small molecular drug	[5]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 2 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
KSG-504	DMC92ER	Investigative	Small molecular drug	[6]
TgBSSL	DMBFX7S	Investigative	NA	[7]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	Clinical pipeline report, company report or official report of Digestive Care.
3	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 874).
4	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 884).
5	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 891).
6	Effects of KSG-504, a new CCK-A receptor antagonist, on gallbladder and gastrointestinal functions. Nihon Yakurigaku Zasshi. 1996 Jan;107(1):33-44.
7	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2872).